HemaSense develops a wearable access‑site monitor that continuously tracks subcutaneous bleeding at femoral puncture sites during post‑operative recovery. The device provides real‑time alerts to clinicians when small volumes of blood accumulate, enabling early, less invasive interventions that can reduce complications, shorten hospital stays, and improve patient outcomes.
Funding
$7.5K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients undergoing percutaneous interventions via femoral access can develop subcutaneous bleeding at the access site, leading to longer hospital stays, additional procedures, and higher morbidity and mortality.
Solution
HemaSense is developing a wearable access‑site monitor that continuously assesses the puncture area during post‑operative recovery. The device detects small volumes of blood accumulating beneath the skin and generates an early alert for clinicians, enabling timely, less invasive interventions before a complication becomes clinically significant. By integrating seamlessly into existing recovery workflows, the monitor aims to reduce the incidence of severe bleeding events, shorten hospital stays, and improve overall patient outcomes.
Target Audience
Primary customers are interventional cardiology and vascular surgery departments in hospitals and outpatient centers that perform femoral artery percutaneous procedures.
Features
- Continuous, real‑time monitoring of the femoral access site for subcutaneous blood accumulation
- Early‑warning alerts delivered to healthcare staff when bleeding thresholds are exceeded
- Compact, wearable form factor designed for use during standard post‑procedure recovery periods
- Compatibility with existing patient monitoring workflows and electronic health record systems
- Non‑invasive sensor technology calibrated to detect low‑volume bleeding events